Idiopathic hypersomnia is a 24-hour disorder. [PDF]
Foldvary-Schaefer N +3 more
europepmc +1 more source
Development of Narcolepsy Type 1 Following COVID-19 Infection in a Patient Previously Diagnosed With Idiopathic Hypersomnia: A Case Report. [PDF]
Pham B, Memon T.
europepmc +1 more source
Correction to: Clinical and polysomnographic changes in idiopathic hypersomnia ten years after the diagnosis. [PDF]
Leu-Semenescu S +6 more
europepmc +1 more source
Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary Results from the DUET Study. [PDF]
Plante DT +10 more
europepmc +1 more source
Prevalence of diagnosed idiopathic hypersomnia among adults in the United States 2019-2023: analysis of healthcare claims. [PDF]
Markt SC +11 more
europepmc +1 more source
Are unrefreshing naps associated with nocturnal sleep architecture specificities in idiopathic hypersomnia? [PDF]
Mombelli S +9 more
europepmc +1 more source
Idiopathic hypersomnia: the long journey from classification to an efficacious drug. [PDF]
Mayer G, Rodenbeck A.
europepmc +1 more source
Xywav: A Treatment Option for Idiopathic Hypersomnia in Down Syndrome. [PDF]
Sanchez S, Allen J.
europepmc +1 more source
Narcolepsy type 2 is an unstable diagnosis and idiopathic hypersomnia has the potential for remission-long-term and cross-sectional observations from the Bern Sleep-Wake Registry. [PDF]
Cavalli RG +6 more
europepmc +1 more source
Safety and pharmacodynamics of a single infusion of danavorexton in adults with idiopathic hypersomnia. [PDF]
Mignot E +8 more
europepmc +1 more source

